The World of Tomorrow According to Liz Parrish

Last week, Liz Parrish, BioViva's founder and CEO, sat down for a chat with the French publication Soon Soon Soon.  During the interview Liz discussed about her vision of a world without suffering from disease, the technologies that will bring that world to fruition, and how BioViva will help. 

Unfortunately, the interview and the Q&A is in French, but google translate does a pretty good job of translating it to English. 

See the entire original article: Le monde de demain selon Liz Parrish, Fondatrice de BioViva

See the Google Translated English version of this article: The World of Tomorrow According to Liz Parrish, Founder of BioViva

2 Comments

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Liz Parrish at Wired Health 2017: Ageing is a Disease. Gene Therapy Could be the Cure

Our CEO, Liz Parrish, spoke at the Wired Health conference in London last month. At the conference Liz spoke about how her son being diagnosed with Type 1 Diabetes was the motivation behind her researching gene therapy treatments for cures. She also spoke about how and why she tested gene therapies on herself. Finally, Liz discussed the  importance of making gene therapy more widely available and how it could ‘cure’ the most prevalent disease of all; aging.

Wired Magazine has also written an article about Liz's talk -- Ageing is a disease. Gene therapy could be the 'cure'

ABOUT WIRED HEALTH 2017
Hundreds of healthcare, pharmaceutical and technology influencers and leaders met at the fifth annual WIRED Health event at 30 Euston Square, London on March 9. Discover some of the fascinating insights from the esteemed speakers here: http://wired.uk/O6xMxJ

ABOUT WIRED EVENTS
WIRED events shine a spotlight on the innovators, inventors and entrepreneurs who are changing our world for the better. Explore this channel for videos showing on-stage talks, behind-the-scenes action, exclusive interviews and performances from our roster of events. Join us as we uncover the most relevant, up-and-coming trends and meet the people building the future.

ABOUT WIRED
WIRED brings you the future as it happens - the people, the trends, the big ideas that will change our lives. An award-winning printed monthly and online publication. WIRED is an agenda-setting magazine offering brain food on a wide range of topics, from science, technology and business to pop-culture and politics.

 

 

 

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

How Humans Are Shaping Our Own Evolution - And BioViva Is Leading The Way

BioViva and our CEO, Elizabeth Parrish, have been featured in the latest National Geographic article about the future of human evolution and how technology is accelerating it. We have chosen some of our favorite sections from the article but we recommend you read the whole thing. Please see the link to the article below.

"Like other species, we are the products of millions of years of adaptation. Now we're taking matters into our own hands."

'Last year the CEO of a company called BioViva claimed to have successfully reversed some of the effects of aging in her own body with injections from a gene therapy her company devised.'

'Aging reversal is just as augmentative as anything else we were talking about. Whatever drugs work to prevent Alzheimer’s will probably also work for cognitive enhancement, and they will work in adults almost by definition. DNA was left in the dust by cultural evolution”, George Church says, "but now it’s catching up.”

NEAR FUTURE: SCIENCE FICTION BECOMES REALITY (Source: Max, D.T. "How Humans Are Shaping Our Own Evolution." National Geographic. N.p., 04 Apr. 2017. Web. 06 Apr. 2017.

NEAR FUTURE: SCIENCE FICTION BECOMES REALITY (Source: Max, D.T. "How Humans Are Shaping Our Own Evolution." National Geographic. N.p., 04 Apr. 2017. Web. 06 Apr. 2017.

“We will transcend all of the limitations of our biology,” Kurzweil promised. “That is what it means to be human—to extend who we are.”

National Geographic

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

The Search To Extend Lifespan Is Gaining Ground... And Bioviva Is Creating The Optimal Solutions

"....using genetically engineered viruses to force old mice to make more telomerase results in a longer lifespan with improved late-life health, without an increased risk of cancer.

Elizabeth Parrish, who is the CEO of BioViva – a company working to develop anti-ageing treatments – recently travelled to Colombia to receive gene therapy to extend her telomeres."

The Conversation

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Gene Therapy: The Woman Who Views Aging As A Disease

Elizabeth Parrish is the founder and CEO of BioViva, a biotech company which advocates gene and cell therapies to treat the diseases of aging. She is a major advocate of patient access to these revolutionary treatments, and became a test subject in September 2015 after receiving treatment for what she believes is the most common 'disease' - aging. To combat the process of aging, she subjected herself to two kinds of therapy - telomerase therapy and myostatin inhibitor.

University Herald

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Our CEO Liz Parrish spoke at Wired Health 2017 about why: Ageing is a disease. Gene therapy could be the 'cure'

"She (Liz Parrish) had spent more than two years studying literature, talking to experts, and had decided to undergo gene therapy – a treatment for genetic disorders that adds genes into cells to replace those that are faulty or absent."

“I was a person who quite honestly felt I had not really contributed that much to society and this was my opportunity to do so.”

“The company was built essentially to prove these therapies work or not,” Parrish says. “Remember BioViva is not a research organisation. We are taking things like gene therapies and using them like technology. We would like to create an open market where people have access to acquiring these technologies, much like you would acquire a cellphone or a computer.”

WIRED

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Liz Parrish - Gene Therapy to Treat the Diseases of Aging on NRK TV's Trygdekontoret

To go to Liz's section in this show click this link: https://youtu.be/E79mOjWDOIY?t=1444

Liz Parrish, CEO of BioViva, speaks about helping people live longer healthier lives by using gene and cell therapies. Liz was speaking at Norways NRK TV show Trygdekontoret.

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

WIRED Health 2017 London: Looking Into The Future of Healthcare

Last week WIRED Health gathered hundreds of leaders and influencers from across the globe in London to discuss the field of health innovation and technology. In addition to their long lists of honors and historic accolades, the unrivaled lineup of speakers brought an infectious enthusiasm for action in healthcare.

MedGadget

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

ABC Lateline: An Interview With Liz Parrish

Jeremy Fernandez speaks to Liz Parrish, the CEO of BioViva - an American biotech developing treatments to slow the ageing process in humans.

ABC Australia

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Adding ages: The fight to cheat death is hotting up

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Becoming the First Transhuman: A Call For The Right Stuff

Who will officially be the first transhuman? 

Transhumanity

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Can this woman cure ageing with gene therapy?

Elizabeth Parrish is CEO of BioViva, a Seattle-based biotech company working to develop treatments to slow the ageing process. In April, the company revealed that Parrish herself had undergone “the first gene therapy successful against human ageing”. The treatment, it claimed, had reversed the biological age of her immune cells by 20 years.

The Guardian 

1 Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Did A Biotech CEO Reverse Her Own Aging Process?

According to BioViva and to interviews with its CEO, Elizabeth Parrish, Parrish received two therapies last year, one to protect against the loss of muscle mass, and one to lengthen her telomeres.

Forbes

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Gene doping in sport could make the Olympics fairer and safer

Elizabeth Parrish of the anti-ageing company BioViva claims to have given herself two kinds of experimental gene therapy, one of which blocks the breakdown of muscle tissue. In other words, your muscles stay strong even if you don’t exercise – and grow faster if you do.

New Scientist

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Biotech execs in search of human guinea pigs find eager subjects: themselves

Liz Parrish, CEO of the biotech BioViva USA Inc., was injected last September with two of the company’s experimental gene therapies. 

STAT News

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Liz Parrish Is Patient Zero in Her Own Anti-Aging Experiment

Elizabeth (Liz) Parrish is the CEO of BioViva, a biotechnology company that focuses on developing gene therapies, and other regenerative therapies, to intervene with human aging.Last September, Parrish added an interesting line to her job description: patient zero for two anti-aging therapies that the company is researching.

Discover Magazine

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

First Data from Anti-Aging Gene Therapy

A biotech company reports that an experimental treatment elongated its CEO’s telomeres. 

The Scientist

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Scientists Claim They've Completed the First Successful Gene Therapy Against Human Ageing

The CEO of Bioviva USA Inc, Elizabeth Parrish, claims to be the first human in world history to have successfully reversed the effects of natural ageing - thanks to experimental gene therapy provided by her company.

Science Alert

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Scientists Say They’ve Completed the First Ever Successful Gene Therapy to Combat Old Age

Elizabeth Parrish, the CEO of BioViva USA Inc, a biotechnology company that “aims to provide regenerative medicine to the masses through gene and cell therapies,” claims to be the first person in history to have successfully reversed one of the hallmark signs of aging with the company’s experimental gene therapy.

The Science Explorer

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Is Silicon Valley Birthing The Next Pro-Lifers?

Elizabeth Parrish is 44, the tough-gunning, sharp-talking CEO of a life-sciences startup, and seemingly full of life herself. But she says she suffers from a deadly disease. Hoping to stave off the sickness, Parrish recently journeyed to a clinic in Colombia, where she underwent a course of therapy that the FDA hasn’t touched with a 10-foot pole. One treatment would alter her telomeres — the stuff at the end of her DNA. The other would inhibit a protein that stops muscle growth.

OZY

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee